Assessing barriers and increasing use of immunization information systems in independent community pharmacies: Study protocol for a randomized controlled trial

被引:4
|
作者
Hastings, Tessa J. [1 ]
Ha, David [3 ]
Fox, Brent, I [2 ]
Qian, Jingjing [2 ]
Lakin, Joni [4 ]
Westrick, Salisa C. [2 ]
机构
[1] Univ South Carolina, Coll Pharm, Dept Clin Pharm & Outcomes Sci, 715 Sumter St, Columbia, SC 29208 USA
[2] Auburn Univ, Harrison Sch Pharm, Dept Hlth Outcomes Res & Policy, 4306 Walker Bldg, Auburn, AL 36849 USA
[3] Stanford Hlth Care, 300 Pasteur Dr, Stanford, CA 94305 USA
[4] Auburn Univ, Coll Educ, Dept Educ Fdn Leadership & Technol, 4072 Haley Ctr, Auburn, AL 36849 USA
来源
基金
美国医疗保健研究与质量局;
关键词
FRAGMENTATION; PROVIDERS; SUPPORT;
D O I
10.1016/j.sapharm.2019.10.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: As the number of providers administering vaccines increases, including pharmacists, there is a concern of fragmented immunization records in state and regional immunization information systems (IIS). In order for IIS to have complete records, it is critical that each provider administering vaccines, including pharmacists, participate and update the IIS each time a vaccine is administered to a patient. In Alabama, provider participation in the state IIS is not mandatory; as a result, less than 25% of adults over the age of 19 have immunization data recorded. IIS participation among independent pharmacies is of particular concern as approximately 40% of Alabama pharmacies are independently owned, but only 27% of these are enrolled in the IIS. Objective: The objective of this report is to describe a study protocol to assess the impact of an IIS training program among community pharmacies’ IIS enrollment and actual participation rates. Methods: The research design is a randomized controlled trial. Study participants are Alabama pharmacists who work in independently owned pharmacies that currently provide at least one type of non-seasonal vaccine and are not currently enrolled in the Alabama IIS. Multiple outcomes including awareness, knowledge, attitudes, intention, IIS enrollment, and IIS participation will be compared between intervention and control groups across three time points (baseline, one-month, and three-months). Individual and organizational factors will be measured to identify any possible associations with outcomes. Implications: The expected outcome is to create an effective training program that is scalable and ready for dissemination. If successful, this training program can be replicated and used to significantly impact the completeness and accuracy of IIS across the U.S., providing the potential for IIS to be used consistently in assessing immunization status and recommending additional vaccines in the pharmacy setting, thereby improving vaccination coverage and making the provision of immunizations safe and efficient. © 2019 Elsevier Inc.
引用
收藏
页码:987 / 992
页数:6
相关论文
共 50 条
  • [31] Protocol for a randomized controlled trial on community education and surveillance on antibiotics use among young children in Nepal
    Nepal, Prajwol
    Subedee, Anup
    Shakya, Henish
    Poudel, Sanjaya
    Joshi, Supriya
    Karki, Kshitij
    Bajracharya, Deepak
    Prentiss, Tyler
    Kaljee, Linda
    Acharya, Yubraj
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 34
  • [32] Improving Detection of Client Complexity in the Community (Impact): A Study Protocol of a Pragmatic Randomized Controlled Trial
    Boak, Jennifer
    Blackberry, Irene
    Rasekaba, Tshepo
    METHODS AND PROTOCOLS, 2021, 4 (04)
  • [33] Addressing the opioid epidemic through community pharmacy engagement: Study protocol for a randomized controlled trial
    Gamble, Abigail
    Mashburn, Trish
    Kennelty, Korey A.
    Look, Kevin A.
    Westrick, Salisa C.
    Evon, Donna M.
    Tudor, Gail
    Carpenter, Delesha M.
    CONTEMPORARY CLINICAL TRIALS, 2022, 121
  • [34] A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial
    Chan, Diana Man Ka
    Cheung, Ka Wang
    Yung, Sofie Shuk Fei
    Lee, Vivian Chi Yan
    Li, Raymond Hang Wun
    Ng, Ernest Hung Yu
    TRIALS, 2016, 17
  • [35] A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial
    Diana Man Ka Chan
    Ka Wang Cheung
    Sofie Shuk Fei Yung
    Vivian Chi Yan Lee
    Raymond Hang Wun Li
    Ernest Hung Yu Ng
    Trials, 17
  • [36] The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial
    Klein, David J.
    Foster, Debra
    Schorr, Christa A.
    Kazempour, Kazem
    Walker, Paul M.
    Dellinger, R. Phillip
    TRIALS, 2014, 15
  • [37] The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial
    David J Klein
    Debra Foster
    Christa A Schorr
    Kazem Kazempour
    Paul M Walker
    R Phillip Dellinger
    Trials, 15
  • [38] Study Protocol for a Randomized Controlled Trial Assessing the Effectiveness of Personalized Computerized Cognitive Training for Individuals With Insomnia
    Tapia, Jose Luis
    Puertas, Francisco Javier
    Dunabeitia, Jon Andoni
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 16
  • [39] Study on the efficiency of virtual reality in the treatment of alcohol use disorder: study protocol for a randomized controlled trial
    Negre, Fanny
    Lemercier-Dugarin, Maud
    Gomet, Romain
    Pelissolo, Antoine
    Malbos, Eric
    Romo, Lucia
    Zerdazi, El-Hadi
    TRIALS, 2024, 25 (01)
  • [40] Tailored patient education on correct drug administration in community pharmacies (TEACH study): study protocol for a multi-centre, parallel-group, cluster-randomized controlled trial
    Lampert, Anette
    Bruckner, Tom
    Haefeli, Walter E.
    Seidling, Hanna M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (05) : 1338 - 1338